Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 222M | 18.1% |
| Gross Profit | 113M | 19.1% |
| Cost of Revenue | 205M | 9.8% |
| Operating expense | 144M | 5.3% |
| Net Income | -31M | 27.9% |
| EBITDA | -27M | 29.1% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 938M | 0.4% |
| Total Liabilities | 704M | 0.8% |
| Total Equity | 234M | 3.8% |
| Shares Outstanding | 65M | 1.4% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | -5.3M | 34% |
| Cash from investing | -3.5M | 30% |
| Cash from financing | -3M | 122.1% |
EPS
Financial Highlights for Tandem Diabetes Care in Q2 '24
Tandem Diabetes Care reported a revenue of 222M, which is a 18.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 113M, marking a 19.1% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 205M, a 9.8% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 144M, showing a 5.3% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -31M, showing a 27.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -27M, showing a 29.1% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Tandem Diabetes Care with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
